1. Home
  2. NMRA vs TCI Comparison

NMRA vs TCI Comparison

Compare NMRA & TCI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NMRA
  • TCI
  • Stock Information
  • Founded
  • NMRA 2019
  • TCI 1983
  • Country
  • NMRA United States
  • TCI United States
  • Employees
  • NMRA N/A
  • TCI N/A
  • Industry
  • NMRA
  • TCI Real Estate
  • Sector
  • NMRA
  • TCI Finance
  • Exchange
  • NMRA Nasdaq
  • TCI Nasdaq
  • Market Cap
  • NMRA 287.6M
  • TCI 248.2M
  • IPO Year
  • NMRA 2023
  • TCI N/A
  • Fundamental
  • Price
  • NMRA $0.65
  • TCI $28.23
  • Analyst Decision
  • NMRA Buy
  • TCI
  • Analyst Count
  • NMRA 8
  • TCI 0
  • Target Price
  • NMRA $9.29
  • TCI N/A
  • AVG Volume (30 Days)
  • NMRA 1.2M
  • TCI 2.5K
  • Earning Date
  • NMRA 05-06-2025
  • TCI 05-08-2025
  • Dividend Yield
  • NMRA N/A
  • TCI N/A
  • EPS Growth
  • NMRA N/A
  • TCI N/A
  • EPS
  • NMRA N/A
  • TCI 0.68
  • Revenue
  • NMRA N/A
  • TCI $47,778,000.00
  • Revenue This Year
  • NMRA N/A
  • TCI N/A
  • Revenue Next Year
  • NMRA N/A
  • TCI N/A
  • P/E Ratio
  • NMRA N/A
  • TCI $41.60
  • Revenue Growth
  • NMRA N/A
  • TCI N/A
  • 52 Week Low
  • NMRA $0.62
  • TCI $25.50
  • 52 Week High
  • NMRA $17.19
  • TCI $32.30
  • Technical
  • Relative Strength Index (RSI)
  • NMRA 22.34
  • TCI 49.21
  • Support Level
  • NMRA $0.64
  • TCI $27.83
  • Resistance Level
  • NMRA $0.83
  • TCI $28.80
  • Average True Range (ATR)
  • NMRA 0.09
  • TCI 0.63
  • MACD
  • NMRA 0.02
  • TCI -0.04
  • Stochastic Oscillator
  • NMRA 6.68
  • TCI 23.48

About NMRA Neumora Therapeutics Inc.

Neumora Therapeutics Inc is a clinical-stage biopharmaceutical company founded to confront the global brain disease crisis by taking a fundamentally different approach to the way treatments for brain diseases are developed. It has rapidly scaled its therapeutic pipeline, which currently consists of seven clinical and preclinical neuroscience programs that target novel mechanisms of action for a broad range of underserved neuropsychiatric disorders and neurodegenerative diseases. The company expects to continue to progress in the development of its pipeline with the planned initiation of multiple clinical trials across its programs over the next 12 to 18 months, which supports numerous anticipated data readouts.

About TCI Transcontinental Realty Investors Inc.

Transcontinental Realty Investors Inc is a fully integrated externally managed real estate company. It operates multifamily and commercial properties throughout the southern United States and also invests in mortgage notes receivable and in the land that is either held for appreciation or development. The company has two business segments: the acquisition, development, ownership, and management of multifamily properties which include the rental of apartments (Residential Segment) and other tenant services, including parking and storage space rental, and the acquisition, development, ownership, and management of commercial properties which are office properties(Commercial Segment). It includes the rental of office space and other tenant services, including parking and storage space rental.

Share on Social Networks: